Connect with us


Glance Technologies Inc (OTCMKTS:GLNNF) Reports Second Quarter 2018 Results



Glance Technologies Inc (OTCMKTS:GLNNF) has released its financial report for the second quarter ended May 31, 2018.

The second quarter was a difficult one for the company

In a statement, Desmond Griffin, the CEO of Glance said the second quarter came with a very difficult proxy content, but he thanked the shareholders for being patient and allowing the company to come out of the difficult moment. He added that the company came out of the contest in a much stronger position and is currently focusing on its long-term strategy. The strategy involves building capacity by improving its technologies. The company is also investing in growing an ecosystem of engaged users and merchants. Recently, the company instituted changes in its management as it focuses on embracing cost-effective and result-oriented business practices.

Financial results

During the second quarter, the company reported $229,000 in revenue compared to $127,000 that was reported in the second quarter of 2017. Out of the total revenue, application and service fees was $153,000, marketing revenue was $25,000 and licensing revenue was $51,000. The company has been reporting big fluctuations in its licensing revenue in the last few quarters. This is because a number of licensing agreements quoted large initial payments. These fluctuations are expected to continue in the future as new agreements are signed.

Operating expenses amounted to $3.9 million in Q2 2018, a big improvement from the $1.3 million that was reported in the Q2 2017. The increase in expense is a reflection of improved business in the last one year.

The company incurred $745,000 in software development cost in Q2 2018. This is a rise from the $130,000 in Q2 2017. The increase in the cost was as a result of expansion of software development team as well as the company’s move into the blockchain industry.

Other expenses in Q2 2018 were investor media and corporate communication expenses which amounted to $347,000. This is a big increase from the $150,000 that was reported in Q2 2017. It is however a drop compared to the $2.4 million that was reported in Q1 2018. The company had earlier indicated that it intends to reduce spending in that category.

Continue Reading


CBD and Rheumatoid Arthritis



Numerous people suffer from arthritis or other types of rheumatic disease that cause joint pain, stiffness and decreased movement. These problems tend to become more severe over time. In addition to this, many sufferers also experience depression and anxiety. A number of sufferers are using CBD for rheumatoid arthritis and finding it has a positive effect on pain, inflammation and helps with their anxiety and depression.

Why does CBD work?

CBD, short for cannabidiol, is one of the cannabinoids found in the cannabis plant. The human body has an endocannabinoid system with CB1 and CB2 receptors. The CB1 receptors are found mainly in the brain and the CB2 receptors in the immune system.

The CB2 receptors are responsible for how your body reacts to pain and inflammation. Rheumatoid Arthritis involves your own immune system attacking your joint tissue. This relationship with the immune system may help to explain why CBD oil helps with the symptoms of rheumatoid arthritis. CBD impacts the CBD receptors indirectly by getting the body to make more of its own endocannabinoids. This has a positive effect on pain and inflammation responses.

The anti-inflammatory effects of CBD could help to slow down the progression of rheumatoid arthritis which can damage joints permanently over time. These effects could also help with other inflammation-related symptoms, such as fever and fatigue. Greenleaf Farm is a trusted supplier of CBD oil that helps to reduce inflammation.

What do the studies say?

The first controlled trial evaluating the use of cannabis-based medicine to treat rheumatoid arthritis was done in 2006. A cannabis-based medicine was compared with using a placebo in 58 patients over a period of five weeks. In comparison with the placebo, the CBS showed statistically significant improvements in pain on movement, pain at rest and the quality of sleep.

A number of studies have linked CBD to a reduction of the symptoms associated with depression. This is significant as individuals suffering from different types of arthritis are more prone to depression than the general population.

So far, the studies look very promising but larger human studies are still needed to fully understand the link between CBD oil and rheumatoid arthritis benefits.

How to use it

There are a number of ways to use CBD oil, such as taking it in capsules by mouth or adding CBD oil to your food or water. You can also buy a therapeutic CBD topical to apply directly to your skin to help with aching joints.

Greenleaf Farms supplies CBD soft gel capsules, a CBD oil and a CBD cream. It’s best to start with a minimal dose to see how your body reacts. If you don’t notice any side effects, you can slowly increase your dosage.

Is it safe to use?

As government regulations regarding the manufacture and sale of CBD are still lacking, you need to make sure you buy from a reputable provider such as Greenleaf Farms.

The risks associated with the use of CBD appear to be extremely low, according to many health experts. The National Institute on Drug Abuse says that CBD seems to be a safe drug without addictive side effects.

MedlinePlus indicates that CBD can sometimes interact with certain prescription medications, mostly those that change and break down in the liver. Another risk is that it can cause drowsiness so if you’re already taking medications to help you sleep or other medications that cause drowsiness, CBD could enhance the effects.

Is it legal?

Its legality depends on a number of factors such as your local laws, geographical location and whether there are other cannabinoids in the oil. Greenleaf Farms extracts its CBD from hemp which it grows in Southern California. All products extracted from hemp are completely legal in the U.S.

Continue Reading


CBD Can Help With Sleep Disorders



If you struggle with a sleep disorder like insomnia, you are not alone. Millions of people across the United States suffer from sleeping disorders and struggle to get a full, restful nights’ sleep every night.

As research is growing, we are finding more and more evidence that supports the hypothesis that CBD can be used to treat sleeping disorders.

Getting a good nights’ sleep is vital to our overall health, how we perform at work and how we interact with our family and friends. Thus, finding a remedy for better sleep is a high priority. But is CBD a wise choice? And can it improve your sleep? Let’s take a closer look:

Can CBD help you sleep better?

If you have been struggling to sleep for a long time, you must have tried a range of things, from yoga and hots baths to antihistamines and sedatives, in an attempt to drift off more easily.

CBD has acquired a more positive reputation more recently with evidence showing it is a powerful health supplement, helping with anything from anxiety and depression to pain and inflammation. In many cases, these conditions contribute to a person’s ability to sleep and by treating the root cause, such as pain, for example, sleep becomes easier.

Since CBD has a relaxing effect on the body, it can certainly help you to sleep better, even if you have a sleep disorder. The effect of CBD and sleep disorders are still being researched; however, CBD oil is already being used in full force by those struggling to sleep.

Where does CBD come from?

CBD is a compound from the cannabis plant. Not to be confused with THC (tetrahydrocannabinol), the psychoactive compound that makes you feel high when smoking recreational marijuana. While both compounds come from the same plant, they have very different effects on the body.

In fact, CBD has been found to counteract the effects of THC by bringing you down from the high. CBD on its own, has exponential health benefits when taken on its own in the form of CBD oil or as a CBD topical. Most CBD products are produced using hemp, which does not contain any THC or only trace amounts.

How does CBD help you sleep?

The human body’s endocannabinoid system produces cannabinoids that the body uses for a variety of processes like sleep, pain, mood and immunity. When you take CBD, it releases phytocannabinoids into your system, enhancing the effect of your endocannabinoids.

Smoking marijuana usually comes with the connotations of feeling relaxed and often sleepy or drowsy. In fact, CBD actually has the opposite effect making you feel more alert.

Since the majority of sleep disorders are the result of chronic pain or stress and anxiety, by treating the cause, patients found sleeping easier when taking a CBD tincture for their anxiety or to treat their pain.

CBD interacts with cannabinoid receptors, CB1 and CB2 in the body to initiate a variety of processes. Generally, CBD enhances the effects of compounds and neurotransmitters that are already present in the body. Thus, it simply improves the functioning of what your body is already doing on a daily basis.

Finding the best CBD product for your sleep disorder

With CBD and sleep disorders, it is recommended that you consult your doctor or medical professional that can guide you in the right direction. You also want to be sure that it won’t interact negatively with any other medication you might be taking.

Find a reputable merchant like Greenleaf Farms that sells good quality CBD, produced under regulations set out by the FDA. You can then be assured that you are purchasing a pure CBD product that will give you the best results.

A few things to look for when comparing CBD merchants include the availability of third-party testing reports, extraction methods, and THC concentration. A money-back guarantee also ensures that the company stands by their product and trusts you will be satisfied with

Continue Reading


Body and Mind Inc. (OTCMKTS:BMMJ) On an Expansion Drive



In mid-June 2019, Body and Mind Inc. (OTCMKTS:BMMJ) announced the expansion into California. NMG Cathedral City, a subsidiary of the company, entered an agreement with Satellites Dip whereby NMG will oversee day-to-day operations of the manufacturing facility under SD’s control.

A tremendous milestone

The cannabis manufacturing facility takes up to 7,800 sq. ft. It is custom built to produce wholesale concentrates and it is designed to produce large volumes of cannabis. Further, the facility’s distillation equipment are state of the art and can produce BHO and ethanol.

Body and Mind (BaM) will be able to produce cannabis oils, wax, shatters, ambrosia and live badder from this facility. The facility has the capability to churn out edibles like Gummies and Pretzel Bites which will expand the product range of the company.

Commenting on the development, Robert Hasman, the President of NMG exuded confidence on the potential for the facility to fuel a rapid expansion of the company. He noted that the agreement offers a tremendous opportunity for BaM to take over the California cannabis market by storm.

This is the first fully licensed facility for NMG and the company hopes to leverage its expertise and top notch formulations to create revenue without having to incur heavy costs of construction of new facilities and licensing. Hasman expects the agreement to result in higher production efficiency and increased output of the company.

Operationalization of the facility is already underway

In an update to shareholders, BaM reiterated its commitment to expansion in the California market. Already, the company has kicked off the operationalization of the facility. Experienced extraction personnel were hired and extraction material which is fully tested has been sourced. The company is now just working on the modalities of the commercial arrangements between SD and other potential partners like cannabis brand owners.

As part of the agreement, SD will license select intellectual property and trademarks to NMG for commercial exploitation. Also, NMG will receive a management fee which will be equal to 30% of the net profit generated by the facility. On its part, NMG will service equipment and extend a loan to SD whose maturity date is June 6, 2020.

Continue Reading

Trending Stories